NCT05937776View on ClinicalTrials.gov

Developing a New Metabolic Imaging Approach (aMRI) for Evaluating Neurological Disease in Patients With Gliomas

RecruitingOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

December 11, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Glioma
Interventions
OTHER

Fludeoxyglucose F-18

Given IV

OTHER

Gadoterate Meglumine

Given IV

PROCEDURE

Contrast-enhanced Magnetic Resonance Imaging

Undergo PET/contrast-enhanced MRI

PROCEDURE

Positron Emission Tomography

Undergo PET/contrast-enhanced MRI

Trial Locations (1)

97239

RECRUITING

OHSU Knight Cancer Institute, Portland

All Listed Sponsors
collaborator

Oregon Health and Science University

OTHER

lead

OHSU Knight Cancer Institute

OTHER